News and Announcements
Proteomics Annual Report to Shareholders 2016
- Published August 30, 2016 10:07AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
26th August 2016, ASX Announcement
Window On The Science – Proteins in medicine
A revolution in medicine is well underway, underpinned by the desire for a deeper understanding of the basis of disease beyond that of classical pathology. Determining what is happening at the molecular level can guide treatment of diseases with precision. At its core, this is about proteins. The value of proteomics technology has made it a cornerstone tool to help understand the dynamics of disease in the ever-changing environment that is the living body.
Proteins are giant, complex biological molecules that carry out all the functions within living systems. They have precise modes of action in the human body. Protein drugs, termed biopharmaceuticals, can provide highly complex functions that simple chemicals cannot perform and moreover, are less likely to cause adverse effects.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
